Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This reflects a maintenance or formatting update rather than any substantive changes to the study information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, indicating a new page snapshot. This reflects a minor update to the page's version/history.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site build update rather than a change to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.5.2 has been added, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded the condition term Malignant lymphoma, large B-cell, diffuse to the study's conditions. Included a new Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.5.0. No obvious changes to the study details or user-facing content are visible compared to the previous version.SummaryDifference0.0%

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.